Methods: All the patients found in our Clinic database affected by ovarian/tubaric carcinoma, who carried a mutation on BRCA1 or BRCA2 genes, and whom the ultrasonographic images were available of, have been included in our study. Results: 26 patients have been recruited in our study. In 100% of the cases histological report revealed that the patients had a high grade (G3) istotype of carcinoma. Nineteen out of twenty-six lesions (73%) were solid and six out of twenty-six lesions (23%) were multilocular-solid. In one patient out of twenty-six (4%) we found a unilocular-solid lesion. The echotexture of the lesions was heterogeneous in twenty-three out of twenty-six patients (88%) and lesions appeared to have irregular margins in twenty-two out of twenty-six of the cases (85%); lesions appeared to be hypoechoic in twenty-five out of twenty-six cases (96%). Vascularisation of the lesions was discrete to high (colour-score 3-4) in twenty-five out of twenty-six patients (96%). Twenty-three out of twenty-six patients (88%) did not have ascites; only three out of twenty-six patients (12%) presented a huge ascites at the ultrasonographic study. Conclusions: In conclusion, in our study ovarian cancer appeared to be a solid or multilocular-solid lesion and, moreover, we found ascites in only three patients (12%), data which has been confirmed by the surgery, even though in 73% of the cases cancer was found at FIGO stage IIIC or IV. Objectives: The aim of this study was to evaluate if IOTA simple rules protocol (SRP) may by effective for evaluation of ovarian masses in pregnant patients. Methods: Retrospective study analysing data of pregnant patients referred to our tertiary centre due to suspicions of ovarian masses between 2013 and 2016. All those patients suspected of adnexal mass underwent sonography according to the IOTA protocol. Surgical procedures were performed if indicated with corresponding histopathology assessment. SRP results were finally compared with histopathology. Results: 122 pregnant patients underwent sonography, 31 of them were qualified for surgery. Mean maternal age of the patients was 29 years (range 17-44). Mean gestational age was 16 weeks (range 5-38). In 90% a unilateral lesion was found and in 10% bilateral adnexal masses were identified. Histopathology evaluation confirmed malignancies in 4 cases and borderline ovarian tumours in 4 subjects. Remaining 23 masses were benign. In one case a postsurgical miscarriage was reported. Conclusions: Ovarian masses during pregnancy require cautious sonographic evaluation in order to identify patients in whom surgical intervention is indicated during pregnancy from those where a observation strategy can be followed. IOTA simple rules protocol is feasible to be used in pregnancy. Objectives: To compare subjective ultrasound assessment and the ADNEX model to differentiate benign and malignant ovarian tumours. Methods: This was a retrospective study including women with ovarian tumours who underwent surgery for these lesions. All patients underwent both transabdominal and transvaginal examination to assess tumour morphology and extent of the disease. Two expert sonographers performed all the scans. The ultrasound examiner assessed tumour morphology according to the IOTA protocol. Finally, the sonographer predicted the tumour as benign or malignant. This assessment was based on subjective evaluation based on knowledge from previously published IOTA studies and was given without knowledge of the results of the ADNEX model. Accuracy of the ADNEX was calculated for the cut-offs of 3% (ADNEX-3%) and 10% (ADNEX-10%) total risk of malignancy. The McNemar's test with the Yates continuity correction was used to compare the accuracy of subjective evaluation with ADNEX-3% and ADNEX-10%, respectively to compare subjective ultrasound assessment and the ADNEX model to differentiate benign and malignant ovarian tumours. Results: A total of 207 women were included in the study with a median (range) age of 52 (15-81) years. Subjective ultrasound evaluation had a significantly higher accuracy (91.8%) in discriminating benign and malignant ovarian tumours in comparison with ADNEX-3% (77.3%; p<0.001) and ADNEX-10% (81.6%; p<0.001). Sensitivity and sensibility of subjective ultrasound evaluation, ADNEX-3% and ADNEX-10% were respectively: 92.2% and 92.4%, 94.0% and 68.9%, 99.1% and 50.0%. Conclusions: This study shows that subjective ultrasound assessment performed by an expert sonographer is more accurate than ADNEX model using two different cut-off points in differentiating benign and malignant ovarian tumours. Future prospective studies with larger population of patients should confirm these preliminary findings. Objectives: In the majority of cases, women with ovarian cancer are not diagnosed until the disease is at an advanced stage and is usually incurable; 60% die of ovarian cancer within 5 years of their diagnosis. The search for new and early diagnostic markers
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Could LARP1 be a driving force in ovarian cancer transformation?
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